TAZ antibody (AA 174-248)
Quick Overview for TAZ antibody (AA 174-248) (ABIN6148874)
Target
See all TAZ AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 174-248
-
Sequence
- NDVLPNSPPY FPRFGQKITV LIGKPFSALP VLERLRAENK SAVEMRKALT DFIQEEFQHL KTQAEQLHNH LQPGR
-
Cross-Reactivity
- Human, Mouse, Rat
-
Characteristics
- Polyclonal Antibodies
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 174-248 of human Tafazzin / TAZ (NP_851830.1).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:1000 - 1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- TAZ (Tafazzin (TAZ))
-
Alternative Name
- TAZ
-
Background
- This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.,TAZ,BTHS,CMD3A,EFE,EFE2,G4.5,LVNCX,Taz1,tafazzin,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,TAZ
-
Molecular Weight
- 25 kDa/27 kDa/28 kDa/29 kDa/30 kDa/31 kDa/33 kDa
-
Gene ID
- 6901
-
UniProt
- Q16635
Target
-